Biogenic Synthesis and Characterization of Chitosan-CuO Nanocomposite and Evaluation of Antibacterial Activity against Gram-Positive and -Negative Bacteria

Synthesis, characterization and evaluation of in vitro potential antimicrobial efficiency of new chitosan hydrogels and their CuO nanocomposites

The phenomenon of microbial resistance and its resulting biofilms to traditional antibiotics is worsening over time. Therefore, the discovery of alternative substances that inhibit microbial activities through mechanisms different from those of known antibiotics requires attention. So, chitosan was crosslinked using different amounts of oxalyl dihydrazide yielding four novel hydrogels; ODHCs-I, ODHCs-II, ODHCs-III, and ODHCs-IV of crosslinking degree 12.17, 20.67, 31.67, and 43.17, respectively. Different amounts of CuO nanoparticles were impregnated into ODHCs-IV, obtaining ODHCs-IV/CuONPs-1 %, ODHCs-IV/CuONPs-3 % and ODHCs-IV/CuONPs-5 % composites. Their structure was emphasized using FTIR, SEM, XRD, TEM, EDX and elemental analysis. Their in vitro antimicrobial and anti-biofilm activities improved with increasing ODH and CuONPs content. ODHCs-IV exhibited minimal inhibition concentration (2 μg/mL) against S. pyogenes that was much lower than Vancomycin (3.9 μg/mL). ODHCs-IV/CuONPs-5 % displayed better inhibition performance than Vancomycin and Amphotericin B against Gram-positive-bacteria and fungi, respectively, and comparable one to that of Vancomycin against Gram-negative-bacteria. ODHCs-IV/CuONPs-5 % displayed much lower minimal biofilm inhibition concentrations (1.95 to 3.9 μg/mL) as compared with those of ODHCs-IV (7.81 and 15.63 μg/mL), against C. albicans, S. pyogenes, and K. pneumonia. ODHCs-IV/CuONPs-5 % composite is safe on normal human cells. Oxalyl dihydrazide and CuONPs amalgamated into chitosan in one formulation promoted its antimicrobial efficiency.

Pro-angiogenic and antibacterial copper containing nanoparticles in PLGA/amorphous calcium phosphate bone nanocomposites

Large bone defects after trauma demand for adequate bone substitutes. Bone void fillers should be antibacterial and pro-angiogenic. One viable option is the use of composite materials like the combination of PLGA and amorphous calcium phosphate (aCaP). Copper stimulates angiogenesis and has antibacterial qualities. Either copper oxide (CuO) nanoparticles (NPs) were therefore added to PLGA/aCaP/CuO in different concentrations (1, 5 and 10 w/w %) or copper-doped tricalcium phosphate NPs (TCP with 2% of copper) were electrospun into PLGA/CuTCP nanocomposites. Bi-layered nanocomposites of PLGA/aCaP with different copper NPs (CuO or TCP) and a second layer of pristine PLGA were fabricated. Two clinical bacterial isolates (Staphylococcus aureus and Staphylococcus epidermidis) were used to assess antibacterial properties of the copper-containing materials. For angiogenesis, the chorioallantoic membrane (CAM) assay of the chicken embryo was performed. The higher the CuO content, the higher were the antibacterial properties, with 10 % CuO reducing bacterial adhesion most effectively. Vessel and cell densities were highest in the 5 % CuO containing scaffolds, while tissue integration was more pronounced at lower CuO content. The PLGA/aCaP/CuO (1 % CuO) behaved similar like PLGA/CuTCP in all angiogenic and antibacterial readouts, based on the same copper fraction. We conclude that CuO NPs or CuTCP NPs are useful components to increase angiogenic properties of nanocomposites and at the same time exhibiting antibacterial characteristics.

Evaluation of the in vitro anti-inflammatory and anti-Helicobacter pylori activities of chitosan-based biomaterials modified with copper oxide nanoparticles

For chemical modification, p-aminobenzoic acid was incorporated into chitosan Schiff base (ACsSB) and chitosan (ACs). Two ACs-based CuO nanoparticles composites; ACs/CuONPs-1 % and ACs/CuONPs-5 %, were also synthesized. Their structures were emphasized utilizing several analytical techniques; elemental analysis, FTIR, 1H NMR, XRD, SEM, EDX and TEM. Compared with standard cyclooxygenase (COX) inhibitor, Celecoxib, the prepared biomaterials showed in vitro selective inhibitory effectiveness against COX-2 enzyme that could be sorted, according to their MIC values that produce 50 % inhibition of COX-2 enzyme activity, as follows: Celecoxib (0.28 μg/mL) > ACs/CuONPs-5 % (4.1 μg/mL) > ACs/CuONPs-1 % (14.8 μg/mL) > ACs (38.5 μg/mL) > ACsSB (58.9 μg/mL) > chitosan (>125 μg/mL). Further, ACs/CuONPs-5 % has more in vitro inhibition efficiency towards Helicobacter pylori (H. pylori) than the other prepared biomaterials. Interestingly, the MIC value of 100 % growth inhibition of H. pylori for ACs/CuONP-5 % is equal to that of drug Clarithromycin (1.95 μg/mL). Thus, ACs/CuONPs-5 % has a promising potential as anti-H. pylori and selective anti-inflammatory agent. ACs/CuONPs-5 % is safe on the human gastric normal cells (GES-1). Therefore, amalgamation of both p-aminobenzoic acid and CuONPs into chitosan extremely promoted its anti-inflammatory and anti-H. pylori activity. This is a promising approach to achieve methods successful to compete the conventional antibiotics.

Recent advances in chitosan-based materials; The synthesis, modifications and biomedical applications

The attention to polymer-based biomaterials, for instance, chitosan and its derivatives, as well as the techniques for using them in numerous scientific domains, is continuously rising. Chitosan is a decomposable naturally occurring polymeric material that is mostly obtained from seafood waste. Because of its special ecofriendly, biocompatible, non- toxic nature as well as antimicrobial properties, chitosan-based materials have received a lot of interest in the field of biomedical applications. The reactivity of chitosan is mainly because of the amino and hydroxyl groups in its composition, which makes it further fascinating for various uses, including biosensing, textile finishing, antimicrobial wound dressing, tissue engineering, bioimaging, gene, DNA and drug delivery and as a coating material for medical implants. This study is an overview of the different types of chitosan-based materials which now a days have been fabricated by applying different techniques and modifications that include etherification, esterification, crosslinking, graft copolymerization and o-acetylation etc. for hydroxyl groups' processes and acetylation, quaternization, Schiff's base reaction, and grafting for amino groups' reactions. Furthermore, this overview summarizes the literature from recent years related to the important applications of chitosan-based materials (i.e., thin films, nanocomposites or nanoparticles, sponges and hydrogels) in different biomedical applications.

Chitosan: Properties and Its Application in Agriculture in Context of Molecular Weight

Chitosan is a naturally occurring compound that can be obtained from deacetylated chitin, which is obtained from various sources such as fungi, crustaceans, and insects. Commercially, chitosan is produced from crustaceans. Based on the range of its molecular weight, chitosan can be classified into three different types, namely, high molecular weight chitosan (HMWC, >700 kDa), medium molecular weight chitosan (MMWC, 150-700 kDa), and low molecular weight chitosan (LMWC, less than 150 kDa). Chitosan shows several properties that can be applied in horticultural crops, such as plant root growth enhancer, antimicrobial, antifungal, and antiviral activities. Nevertheless, these properties depend on its molecular weight (MW) and acetylation degree (DD). Therefore, this article seeks to extensively review the properties of chitosan applied in the agricultural sector, classifying them in relation to chitosan's MW, and its use as a material for sustainable agriculture.

Comparative analysis of phyto-fabricated chitosan, copper oxide, and chitosan-based CuO nanoparticles: antibacterial potential against Acinetobacter baumannii isolates and anticancer activity against HepG2 cell lines

The aim of this study was to provide a comparative analysis of chitosan (CH), copper oxide (CuO), and chitosan-based copper oxide (CH-CuO) nanoparticles for their application in the healthcare sector. The nanoparticles were synthesized by a green approach using the extract of Trianthema portulacastrum. The synthesized nanoparticles were characterized using different techniques, such as the synthesis of the particles, which was confirmed by UV-visible spectrometry that showed absorbance at 300 nm, 255 nm, and 275 nm for the CH, CuO, and CH-CuO nanoparticles, respectively. The spherical morphology of the nanoparticles and the presence of active functional groups was validated by SEM, TEM, and FTIR analysis. The crystalline nature of the particles was verified by XRD spectrum, and the average crystallite sizes of 33.54 nm, 20.13 nm, and 24.14 nm were obtained, respectively. The characterized nanoparticles were evaluated for their in vitro antibacterial and antibiofilm potential against Acinetobacter baumannii isolates, where potent activities were exhibited by the nanoparticles. The bioassay for antioxidant activity also confirmed DPPH scavenging activity for all the nanoparticles. This study also evaluated anticancer activities of the CH, CuO, and CH-CuO nanoparticles against HepG2 cell lines, where maximum inhibitions of 54, 75, and 84% were recorded, respectively. The anticancer activity was also confirmed by phase contrast microscopy, where the treated cells exhibited deformed morphologies. This study demonstrates the potential of the CH-CuO nanoparticle as an effective antibacterial agent, having with its antibiofilm activity, and in cancer treatment.

Fabrication of chitosan and Trianthema portulacastrum mediated copper oxide nanoparticles: Antimicrobial potential against MDR bacteria and biological efficacy for antioxidant, antidiabetic and photocatalytic activities

Biopolymer based metal oxide nanoparticles, prepared by eco-friendly approach, are gaining interest owing to their wide range of applications. In this study, aqueous extract of Trianthema portulacastrum was used for the green synthesis of chitosan base copper oxide (CH-CuO) nanoparticles. The nanoparticles were characterized through UV-Vis Spectrophotometry, SEM, TEM, FTIR and XRD analysis. These techniques provided evidence for the successful synthesis of the nanoparticles, having poly-dispersed spherical shaped morphology with average crystallite size of 17.37 nm. The antibacterial activity for the CH-CuO nanoparticles was determined against multi-drug resistant (MDR), Escherichia coli, Pseudomonas aeruginosa (gram-negative), Enterococcus faecium and Staphylococcus aureus (gram-positive). Maximum activity was obtained against Escherichia coli (24 ± 1.99 mm) while least activity was observed against Staphylococcus aureus (17 ± 1.54 mm). In-vitro analysis for biofilm inhibition, EPS and cell surface hydrophobicity showed >60 % inhibitions for all the bacterial isolates. Antioxidant and photocatalytic assays for the nanoparticles showed significant activities of radical scavenging (81 ± 4.32 %) and dye degradation (88 %), respectively. Antidiabetic activity for the nanoparticles, determined by in-vitro analysis of alpha amylase inhibition, showed enzyme inhibition of 47 ± 3.29 %. The study signifies the potential of CH-CuO nanoparticle as an effective antimicrobial agent against MDR bacteria along with the antidiabetic and photocatalytic activities.

Manganese Dioxide Nanoparticles Prepared by Laser Ablation as Materials with Interesting Electronic, Electrochemical, and Disinfecting Properties in Both Colloidal Suspensions and Deposited on Fluorine-Doped Tin Oxide

Nanoparticles (NPs) of α-MnO₂ have high applicability in photoelectrochemical, heterogeneous photocatalysis, optical switching, and disinfection processes. To widen this panorama about MnO₂ NPs, the formation of this material by laser ablation and deposition by dip-coating on fluorine-doped tin oxide (FTO), were considered in this study. The optical, spectroscopic, electrochemical characterization, and the evaluation of the antimicrobial activity, plus the photocatalytic response, were measured herein in colloidal media and deposited. For the deposition of NPs on FTO sheet, an anode is produced with a pseudocapacitive behavior, and 2.82 eV of band gap (GAP) in comparison with colloidal NPs for a value of 3.84 eV. Both colloidal suspension and deposited NPs have intrinsic antibacterial activity against two representative microorganisms (E. coli and S. aureus), and this biological activity was significantly enhanced in the presence of UVA light, indicating photocatalytic activity of the material. Thus, both the colloidal suspension and deposited NPs can act as disinfecting agents themselves or via light activation. However, an antibacterial behavior different for E. coli and S. aureus was observed, in function of the aggregation state, obtaining total E. coli disinfection at 30 min for deposited samples on FTO.

Antimicrobial Properties of CuO Particles Deposited on a Medical Mask

Medical face masks help to reduce the transmission of pathogens, however, the number of infections caused by antimicrobial-resistant pathogens continues to increase. The aim of this study was to investigate the antimicrobial effect of an experimental medical mask layer coated with copper oxide using an environmentally friendly non-thermal physical vapour deposition approach. Pure CuO nanoparticles were successfully deposited on the middle layer of a face mask. The particles were distributed in different size clusters (starting from less than 100 nm dots going up to about 1 µm cluster-like structures). The CuO clusters did not form uniform films, which could negatively influence airflow during use of the mask. We investigated the antimicrobial properties of the experimental mask layer coated with CuO NPs using 17 clinical and zoonotic strains of gram-negative, gram-positive, spore-forming bacteria and yeasts, during direct and indirect contact with the mask surface. The effectiveness of the coated mask layer depended on the deposition duration of CuO. The optimal time for deposition was 30 min, which ensured a bactericidal effect for both gram-positive and gram-negative bacteria, including antimicrobial-resistant strains, using 150 W power. The CuO NPs had little or no effect on Candida spp. yeasts.

Corrosion Inhibition Evaluation of Chitosan–CuO Nanocomposite for Carbon Steel in 5% HCl Solution and Effect of KI Addition

Chitosan–copper oxide (CHT–CuO) nanocomposite was made by an in-situ method utilizing olive leaf extract (OLE) as reductant. The OLE mediated CHT–CuO nanocomposite containing varying amount of chitosan (0.5, 1.0 and 2.0 g) was evaluated as corrosion inhibitor for X60 carbon steel in 5 wt% hydrochloric acid solution. The corrosion inhibitive performance was assessed utilizing weight loss and electrochemical impedance spectroscopy, linear polarization resistance and potentiodynamic polarization techniques complemented with surface assessment of the corroded X60 carbon steel without and with the additives using scanning electron microscopy/energy dispersive X-ray spectroscopy and 3D optical profilometer. The effect of KI addition on the corrosion protection capacity of the nanocomposites was also examined. Corrosion inhibitive effect was observed to increase with increase in the nanocomposites dosage with the highest inhibition efficiency (IE) achieved at the optimum dosage of 0.5%. The order of corrosion inhibition performance followed the trend CHT1.0–CuO (90.35%) > CHT0.5–CuO (90.16%) > CHT2.0–CuO (89.52%) nanocomposite from impedance measurements. Also, IE was found to increase as the temperature was raised from 25 to 40 °C and afterwards a decline in IE was observed with further increase in temperature to 50 and 60 °C. The potentiodynamic polarization results suggest that the nanocomposites alone and in combination with KI inhibited the corrosion of X60 carbon steel by an active site blocking mechanism. Addition of KI upgrades the IE of the nanocomposites but is not attributable to synergistic influence. The lack of synergistic influence was confirmed from the computed synergism parameter (S1) which was found to be less than unity with values of 0.89, 0.74 and 0.75 for CHT0.5–CuO, CHT1.0–CuO and CHT2.0–CuO nanocomposites, respectively, at 60 °C. Furthermore, KI addition improved the IE with rise in temperature from 25 to 60 °C. Surface analysis results confirm the formation of a protective film which could be attributed to the adsorption of the nanocomposites on the carbon steel surface.